Try our Advanced Search for more refined results
Life Sciences - June, 2010
205 articles
- Interbrand Can't Dodge Marksmen Defense Claims
- Medical Process Patent Cases First Big Test For Bilski
- Alcon Shareholders Seek 2nd Shot In Merger Suit
- La. Can't Recover Vioxx Payments From Merck: Judge
- USPTO Nixes Apotex Bid for Plavix Patent Re-Exam
- Sanofi Settles False Patent Marking Qui Tam Suit
- Jones Day Reps Sanofi In $560M TargeGen Buy
- Wyeth Can't Combine Texas Prempro Cases: Judge
- Evident, Invitrogen Settle Quantum Dot IP Squabble
- Proskauer, Jones Day Rep Celgene In $3B Abraxis Buy
- Clinical Trials And The Learned Intermediary Doctrine
- FDA Warns Baxter Over Dialysis Systems
- AstraZeneca Crestor Patent Found Valid, Enforceable
- Bristol-Myers Execs Escape Fraud Charges With Catch
- Bilski Prompts Remand In Medical Process Cases
- Reports Spur Lawmakers To Call For End To Avandia
- Thompson Hine Adds Arnold & Porter Product Pro
- Will Inequitable Conduct Finally Be Reformed?
- Mylan Barred From Selling Generic Oracea
- Judge Affirms Bar On Teva Discovery In Aricept IP Suit
- High Court Lets Nigerians' Pfizer Suits Stay In US
- Bayer To Pursue IP Row Over Teva's Gianvi In Nev.
- Abbott Goes After Mylan Over Simcor ANDA
- Genzyme Targets Sandoz Over Kidney Drug ANDA
- Midland Exits Life Technologies' Assay Patent Suit
- UK Court Rules Prior Art After Priority Date Counts
- One A Day False Ad Action Survives Dismissal Bid
- SEC Wants Asset Info From Taro Pharma Exec, Sons
- Lack Of Guidance In Bilski Will Spark Suits: Attys
- Jury Stuns Merck With $8M Verdict For Fosamax Plaintiff
- New Star Cuts Deal In CardioFocus Laser Patent Row
- Amgen Shareholders Appeal ERISA Loss To 9th Circ.
- Zydus Gives Up Attempt To Market Generic Astelin
- Gilead To Pay Up To $120M For CGI Pharmaceuticals
- Merck Homes In On Defect Claims In Fosamax Closing
- Fed. Circ. Sends Hip Replacement Patent Suit To Ind.
- J&J Scores Another Win Over Fake OneTouch Strips
- 7th Circ. Upholds Remand Of Bayer Trasylol Suits
- ITC Says Toyota Must Face Hybrid Patent Suit
- Purdue Claims Construction Prevails In Embeda IP Suit
- The Future Of Biosimilars In Health Care And Litigation
- UK Court Finds Smith & Nephew Infringed Kinetic's IP
- Fosamax Jurors Can Consider Plaintiff's Smoking
- Trademarks May Help Companies Skirt Patent Woes
- Spectranetics To Pay $8.9M To End Securities Suits
- Vanderbilt V. ICOS And Proving Joint Inventorship
- Trasylol Plaintiffs Lose Bid To Use Expert
- Respironics Apnea Patent Ruled Valid But Not Infringed
- Unmasking Confidential Witnesses?
- Apotex Fends Off Patent Suit Over Pinkeye Treatment
- Innovative Managing Partner: Cravath's Evan Chesler
- Schering Fails To Thwart Securities Suit Over Vytorin
- Jaw Issues Not A Reason To Stop Fosamax: Expert
- Insurers Escape Liability In Mylan Antitrust Suits
- Aventis' Allegra Patent Survives Impax Assault
- 2nd Circ. OKs $5M Deal In Telik Cancer Drug Suit
- Reed Smith Snags Neal Gerber Health, Insurance Trio
- Lenox-MacLaren, Medtronic End Bone Mill Patent Row
- Mylan Appeals Dismissal Of Prilosec Antitrust Claims
- Avoiding Pitfalls In Pharma Trademark Clearance
- Class Action From Digitek MDL Tossed
- Merck Expert Decries FDA Fosamax Report
- Judge Throws Trading Suspect's Bail Plan In Limbo
- Skadden Reps Valeant In $3.2B Biovail Merger
- Prempro Punitive Damages Case Back In District Court
- Smith & Nephew Wins Ban On Arthrex Surgery Device
- Philips Sues Zoll Medical Over Defibrillator Patents
- Solvay Cert Refusal Leaves FCA Circuit Split In Place
- Fair Ex Parte Communication With Doctors In MDLs
- High Court Won't Hear Procrit Whistleblower Suit
- UBS Insider Trading Suspect Still In Custody
- ABA Drums For New Inequitable Conduct Rule
- AstraZeneca To Pay $103M To Settle AWP Claims
- Judge Buries Barr's Plan For Generic Argatroban
- MDs Take $10M Greenberg Malpractice Suit To Fed. Circ.
- 2nd Circ. Affirms $2M Ruling Against Colonial Fund
- Alcon Shareholders Can't Keep Merger Suit In US
- Walgreen, CVS Caremark Resolve Drug Plan Feud
- Fosamax Plaintiff Takes The Stand
- Judge Nixes Infosint's $15M Patent Win Over Citalopram
- 6th Circ. Reverses Sulzer Win In Implant Defect Case
- Red Cross Draws $16.2M In FDA Blood Safety Fines
- Pfizer Sues Mylan To Block Generic Sutent
- $33M Fee Award From E-Ferol Settlement Stays Intact
- Impax Asks To Appeal Budeprion MDL Dismissal Bid
- False Statement Claims V. Biovail Execs To See Trial
- Teva To Alter Ads For Generic Yaz After Bayer Outcry
- AstraZeneca Fails To Block Generic Nexium In Canada
- Depomed Yanks Diabetes Drug Glumetza
- Myriad Appeals Invalidation Of Human Gene Patents
- How Long Can A Patentee Wait For A PTA Appeal?
- Health Care Reform 101: For Life Sciences Cos.
- Health Care Reform 101: For Physicians
- Oil Spill Defendants Bring On Major Firms
- Covidien Snaps Up Somanetics For $250M
- MedImmune Jabbed With $15M Flu Vaccine Royalty Suit
- FDA Launches Data-Sharing System For New Drugs
- Allergan Goes After Apotex Over Combigan ANDA
- Fosamax Trial Expert Stumbles Over Report Origins
- Alpin, AIM Settle I-Flow Drug Pump Patent Claims
- Abbott Loses Bid To Toss Humira Cancer Suit
- Bayer Accuses Teva Of Falsely Advertising Yaz Generic
- Pa. Hospital Takes Amgen Tying Fight To 3rd Circ.
- FTC Seeks To Allay Doctors' Antitrust Fears
- Quinn Emanuel Snags Biotech Patent Pro From Howrey
- J&J Gets Pa.'s Off-Label Risperdal Suit Tossed
- Hypertension Drugs Tied To Higher Cancer Risk
- AMRI, Sanofi Win Injunction Blocking Generic Allegra
- Abbott Sales Reps Ruled Not Exempt From FLSA
- FDA Warns Gene Test Makers They Need Agency OK
- Trade Secrets Claim Added To Patent Suit Over Delsym
- Genzyme Targets Anchen Over Hectorol ANDA
- ScImage Settles In Acacia Unit's Imaging Patent Suit
- House Panel Probes Wyeth Off-Label Allegations
- Supreme Court To Hear Matrixx Zicam Securities Case
- Ciba, Novartis Partly Dodge Contact Lens Injury Suit
- Judge Rejects Dismissal, Injunction In Aldara IP Spat
- A&E Slammed For Forum Shopping In Reality TV Dispute
- Schering-Plough Off-Label Marketing MDL Dunzo
- US Wants Dey's AWP Evidence Against It Tossed
- Schering Loses Bid To Split Suit Over Generic Vytorin
- Applera Seeks Enzo IP Spat Stay For High Court Appeal
- DOJ Requires Divestiture For Amcor's $2B Alcan Buy
- FTC Fights Nixing Of AndroGel Reverse Payment Suit
- GSK Expands In Argentina With $253M Phoenix Buy
- Workers Face Uphill Battle In Bias Suits, Study Says
- Otsuka Sues Zydus To Block Generic Abilify
- Fed. Circ. Remands Stryker IP Suit, Orders New Judge
- FDA Rebukes Pfizer Over Late Reports Of Side Effects
- ITC To Review Drugs Up For Duty-Free Treatment
- Digitek Plaintiffs Want 2nd Look At Class Cert.
- Neurontin Judge Doubts Atty Can Rep 292 Plaintiffs
- Smith & Nephew Sues Rival Over Cutting Tool Patent
- Apotex Dodges Extra Damages In Prilosec Patent Suit
- Mayer Brown Reps Healthcare Solutions In $517M Sale
- Fosamax Witness Slams Merck's Bone Death Claims
- Merck, Upsher-Smith Appeal Class Cert. In K-Dur Suit
- FDA Warns Drugmaker Aveva Over Plant Problems
- All Eyes On J&J Case As FDA Tests Criminal Powers
- Blue Cross Sues Pfizer Over Off-Label Marketing
- 1-800 Contacts Sues Walgreen Over Web Ads
- Medtronic Sues Bovie Over Surgical Device Patent
- USPTO Issues 1st Parthenogenetic Stem Cell Patent
- Icahn Gets 2 Seats On Genzyme Board In Proxy Deal
- Pfizer, West-Ward Recall IV Drugs Over Contamination
- J&J Seeks Dismissal Of Omnicare Kickback Case
- Plaintiff In Fosamax Bellwether Says Merck Hid Risks
- Endo Resolves Opana Patent Suits V. Impax, Sandoz
- No Win Yet For Royal Sun In Stolen Kits Coverage Spat
- Settlement Halts Trial In Mentor ObTape MDL
- Aso Slapped With Patent Suit Over Bandages
- Spring Supreme Court Roundup
- Wockhardt Fails To Nix Sepracor's Lunesta Patents
- Sanofi, Abbott Fail To Halt Release Of Generic Tarka
- Tying Suit Against Amgen Over Blood Drug Tossed
- 3rd Circ. Nixes Class' Appeal Of Fen-Phen Atty Fees
- Proskauer Reps Grifols In $3.4B Talecris Buy
- Iovate Trims Claims In $13.5M Hydroxycut MDL Case
- Biotech Co.'s Suit Over Mintz Levin IP Work Trimmed
- Stryker Implant Suit Meets Preemption Test: Judge
- Lawyers Gear Up For Round 2 Of Fosamax Bellwether
- Toyota Says KSR Ruling Makes Hybrid Patent Obvious
- KV Unit Sales Rep Seeks Cert. In OT Collective Suit
- Chem Rx To Keep Biz Open With Existing Cash
- St. Jude To Pay $3.7M Over Hospital Kickback Scheme
- DOJ Asks 2nd Circ. To Rehear Bayer Pay-For-Delay Suit
- Latest Watson CEO Brief Rips Motive For FTC Subpoena
- The 4 Factors Behind The Cipro En Banc Hearing
- Groups Urge Fed. Circ. To Rethink Novo Nordisk Win
- Prempro Plaintiffs Try To Block Preemption Defense
- Fed. Circ. Deems Purdue's Tramadol Patents Invalid
- Wyeth Wins Brawl Over Heartworm Drug In 1st Circ.
- Sequenom VP Inflated Down Syndrome Test: SEC
- Javelin Says Hospira Breached $145M Merger Deal
- ERISA Suit Over GSK's Stiefel Acquisition To Proceed
- House Panel Turns Up Heat On J&J Over Recalls
- USPTO Reaffirms Solodyn Patent
- Dr. Reddy's Agrees To Hold Off On Generic Allegra
- Biotechs Face Higher Bar For Induced Infringement
- Shire Sues Anchen Over Generic Intuniv
- Ex-Goldman Analyst Fined $28M For Insider Trading
- 10th Circ. Remands Wyeth, GSK Suits Over Preemption
- Abbott's Appeal Bid Nixed In Norvir Pricing Suits
- Bayer Yaz Patents Invalid, Teva Claims
- Fed. Circ. Nixes $15.7M Award In Blood Device IP Suit
- USTR Preps More Drugs For Duty-Free Treatment
- Ortho, Amneal Settle Patent Spat Over Ultracet
- Flonase Indirect Purchasers Press For Class Status
- Teva Fails To Block Paddock's Cenestin ANDA
- Court Clears Fen-Phen Attys Of Malpractice Claims
- Biogen Sues Bayer, Others Over Multiple Sclerosis Drug
- Mega-T Maker To Pay $2.5M Over Diet Pill Claims
- FDA Warns Dexcom Over Glucose Monitor Problems
- 'Litigation Prenup' Could Face Obstacles In Court
- Allergan Strikes Deal In Dry Eye Treatment Patent Suit
- 3rd Circ. Affirms Nixing Of Kickback Suit V. Stryker
- Bayer Sues Teva Over Generic Yaz
- GSK Settles 1st Avandia Suit Slated For Trial
- Accentia Files Plan Aimed At Boosting MS Drug
- FTC Pushes For Watson CEO To Testify In Provigil Probe
- DOJ Seeks More Info On Oracle, Phase Forward Merger
- SG Urges Justices To Reject Pfizer Nigeria Case
- Novo Nordisk Hit With Antitrust Action Over Prandin
- Case Of The Moenchies: Moench Provision Expansion
- Covidien To Pay $2.6B For Vascular Device Maker